PMA device
Tendyne Transcatheter Mitral Valve System
Abbott Medical · Prosthesis, Mitral Valve, Percutaneously Delivered (NPU, Class III) · First FDA decision May 23, 2025, newest Oct 4, 2025Mitral regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
Breakthrough-designated
Device trials
5
Naming "Tendyne"
MAUDE reports
48
Brand "Tendyne", since 2015
PubMed studies
111
Mentioning "Tendyne"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tendyne Transcatheter Mitral Valve System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Tendyne Transcatheter Mitral Valve SystemPMA supplement
P240042-S002 · Decided Oct 4, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, mitral valve, percutaneously delivered (NPU) · Cardiology
- Tendyne Transcatheter Mitral Valve SystemBreakthroughPMA
P240042 · Decided May 23, 2025 · 177 days after receipt
Device type: Prosthesis, mitral valve, percutaneously delivered (NPU) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve RegurgitationNational analysisReview closedCAG-00438RUpdated Sep 23, 2026
- Transcatheter Mitral Valve Repair (TMVR)National analysisReview closedCAG-00438RUpdated Sep 23, 2026
- Transcatheter Mitral Valve Repair (TMVR)National analysisReview closedCAG-00438NUpdated Sep 23, 2026
- Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve RegurgitationNational determinationOn the books20.33Updated Aug 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Tendyne", any status and sponsor, newest update first.
- Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral RegurgitationPivotal-lookingActive, not recruiting
Abbott Medical DevicesPublic (ABT)
NCT03433274 · 103 participants · Start Jun 15, 2018 · Primary completion Apr 29, 2024
Device: Tendyne Mitral Valve System; MitraClip System · For: Mitral Regurgitation; Mitral Insufficiency; Mitral Valve Insufficiency and 5 more
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 78 sites in all
- Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral RegurgitationActive, not recruiting
Abbott Medical DevicesPublic (ABT)
NCT04818502 · 200 participants (planned) · Start May 4, 2021 · Primary completion Apr 4, 2024
Device: Tendyne™ Mitral Valve System · For: Mitral Valve Regurgitation
Sites: Linz, Austria; Leuven, Belgium; Olomouc, Czechia · 36 sites in all
Abbott Medical DevicesPublic (ABT)
NCT02321514 · 191 participants · Start Nov 2014 · Primary completion Jul 2020
Device: Tendyne Mitral Valve System · For: Mitral Valve Regurgitation
Sites: Scottsdale, Arizona; Washington D.C., District of Columbia; Clearwater, Florida · 40 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Tendyne", and for the whole product code for context.
This brand
48 reports: 9 malfunction, 27 injury, 12 death
Whole product code NPU
2,081 reports: 149 malfunction, 1,500 injury, 432 death
Newest reports for this brand
2135147-2026-07115 · Received Oct 23, 2026 · Event dated Sep 28, 2026
Device type: Prosthesis, Mitral Valve, Percutaneously Delivered (NPU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Heart Failure/Congestive Heart Failure
2135147-2026-06916 · Received Oct 13, 2026 · Event dated Sep 22, 2026
Device type: Prosthesis, Mitral Valve, Percutaneously Delivered (NPU)
Device problem as coded: Perivalvular Leak
Patient problem as coded: Arrhythmia; Pleural Effusion; Obstruction/Occlusion
- Tendyne¿ Mitral ValveInjury
2135147-2026-06669 · Received Oct 2, 2026 · Event dated Sep 8, 2026
Device type: Prosthesis, Mitral Valve, Percutaneously Delivered (NPU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Tissue Injury
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Tendyne"[tiab]. The summary above synthesizes these.
- A tensed Tendyne.
Grinberg D, Pozzi M, Bernard C, et al. · Eur J Cardiothorac Surg · 2020Case Reports
- Tendyne valve facilitated by antegrade anterior mitral laceration.
Alarcón R, Barreiro-Pérez M, Estévez-Loureiro R · Rev Esp Cardiol (Engl Ed) · 2022
- Apical defect following Tendyne valve placement.
Howard T, Prasada S, Cremer P, et al. · J Nucl Cardiol · 2022
- Unusual Postoperative Course After Tendyne Implantation.
Piperata A, Pernot M, Issa N, et al. · Circ Cardiovasc Imaging · 2022
- Transcatheter mitral valve implantation: Tendyne.
Moat NE, Duncan A, Quarto C · EuroIntervention · 2016Review, Video-Audio Media
- Early clinical results with the Tendyne transcatheter mitral valve replacement system.
Beller JP, Rogers JH, Thourani VH, et al. · Ann Cardiothorac Surg · 2018Editorial
- 3-Year Outcome of Tendyne Transcatheter Mitral Valve Replacement to Treat Severe Symptomatic Mitral Valve Regurgitation.
Duncan A, Sorajja P, Dahle G, et al. · JACC Cardiovasc Interv · 2024Letter, Research Support, Non-U.S. Gov't
- Transcatheter Mitral Valve Replacement with Tendyne.
Niikura H, Gössl M, Sorajja P · Interv Cardiol Clin · 2019Review
- Management of Massive Thrombosis of a Tendyne Valve: The Importance of Heart Valve Centers.
Urena M, Vahanian A · JACC Case Rep · 2024Editorial
- Transapical Transcatheter Mitral Valve Implantation with the Tendyne Valve: The Swiss Experience.
Nucera M, Miazza J, Praz F, et al. · Thorac Cardiovasc Surg · 2024
- Rendezvous of CoreValve Skirt With Tendyne Crown.
Puehler T, Saad M, Haneya A, et al. · JACC Cardiovasc Interv · 2021Research Support, Non-U.S. Gov't
- LAMPOON to Facilitate Tendyne Transcatheter Mitral Valve Replacement.
Khan JM, Lederman RJ, Devireddy CM, et al. · JACC Cardiovasc Interv · 2018Case Reports, Letter
Other devices of this type
Also filed under product code NPU.
- SAPIEN M3 Transcatheter Mitral Valve Replacement SystemEdwards Lifesciences, LLC · PMA 2026
- Edwards SAPIEN 3Edwards Lifesciences, LLC · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.